¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21
±³À°ÀÏÀÚ : 2020-03-21
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : ILD School 2020
ÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : °£Áú¼ºÆóÁúȯ(ILD)¿¬±¸È¸
´ã´çÀÚ : ±è½ÃÀ±
¿¬¶ôó : 02-575-3825  
À̸ÞÀÏ : katrd@hanmail.net      
±³À°Á¾·ù : ³»°ú, °áÇÙ°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 10,000¿ø      
ºñ°í »çÀüµî·Ï : 10,000¿ø ÇöÀåµî·Ï : 20,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 14:10~14:40 Idiopathic Pulmonary Fibrosis: Current Management and Future Perspectives  ÃÖ¼±¹Ì(¼­¿ïÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 14:40~15:10 An Evolving ILD : Pleuroparenchymal Fibroelastosis  ÀÌÀçÇÏ(ÀÎÁ¦ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 15:10~15:40 Diagnostic Approach to Diffuse Cystic Lung Disease: Radiologists¡¯ Perspectives  Ã¤ÀºÁø(¿ï»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 16:10~16:40 Progressive Fibrosing-ILD: Concept and Pharmacologic Management  ¼ÛÁø¿ì(¿ï»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 16:40~17:10 Systemic Sclerosis Associated ILD: where do we stand  ÀÌÁ¾¹Î(°¡Å縯ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 17:10~17:40 Chronic Hypersensitivity Pneumonitis: the New Diagnostic Criteria and Treatment  À¯È«¼®(¼º±Õ°üÀÇ´ë ³»°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" »ï¼º¼­¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æºÏ´ëÇб³º´¿ø ¿µ³² ³»°ú°è ½ÅÀåÀÌ½Ä ¿¬±¸È¸ Á¦25Â÷ ÇмúÁý´ãȸ : 2020-03-21
´ÙÀ½±Û 2020 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2020-03-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20340 ¼­¿ï Çѱ¹½ÇÇèÇ÷¾×ÇÐȸ 2024 KSEH Spring Meeting – Revolutionizing technologies to overcome hurdles of cancer research & therapy : 2024-05-17 0 90 2024-04-03
20339 ¼­¿ï (¿Â¶óÀÎ) À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-GERDÀÇ ÃÖ½ÅÄ¡·á-°¡À̵å¶óÀÎÀ» Áß½ÉÀ¸·Î : 2024-05-16 0 101 2024-04-03
20338 ºÎ»ê ´ëÇÑÀçÈ°ÀÇÇÐȸ Á¦164Â÷ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2024-05-16 0 108 2024-04-03
20337 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-05-13 0 123 2024-04-03
20336 ¼­¿ï Çѱ¹ÀÓ»ó°íÇ÷¾ÐÇÐȸ 2024³â Ãá°èÇмú¼¼¹Ì : 2024-05-12 0 174 2024-04-03
20335 ¼­¿ï ´ëÇѼö¸é¿¬±¸ÇÐȸ °³¿øÀÇ ¡¤ ºÀÁ÷ÀÇ ¿¬¼ö±³À° : 2024-05-12 0 163 2024-04-03
20334 ¼­¿ï 2024³â ¼­Ãʱ¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-12 0 109 2024-04-03
20333 Ãæ³² Á¦10ȸ ¼øõÇâ´ëÇб³ÀÇ°ú´ëÇРõ¾Èº´¿ø ¼ÒÈ­±â³»°úÇб³½Ç ¼ÒÈ­±âº´ ½ÉÆ÷Áö¿ò : 2024-05-11 0 144 2024-04-03
20332 ¼­¿ï ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ : The 17th SMC Vascular Symposium, 2024 : 2024-05-11 0 93 2024-04-03
20331 ºÎ»ê Çѱ¹¿Ü°ú·Îº¿¼ö¼úÇÐȸ 2024 KAROS Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-05-10 0 91 2024-04-03
20330 ¼­¿ï 2024 °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ Áý´ãȸ : 2024-05-09 0 79 2024-04-03
20329 ¼­¿ï (¿Â¶óÀÎ) À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-½Å°æÅ뼺 ÀÌÅëÀÇ Æ¯Â¡°ú ¾à¹°Ã³¹æ ¿ä·É, ¾à¹° ÁÖÀÇ»çÇ× : 2024-05-09 0 100 2024-04-03
20328 ºÎ»ê Çѱ¹¿Ü°ú·Îº¿¼ö¼úÇÐȸ 2024 KAROS Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-05-09 0 133 2024-04-03
20327 ºÎ»ê 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿ò : 2024-05-04 0 115 2024-04-03
20326 °æ³² Á¦37Â÷ ´ëÇÑ´ç´¢º´ÇÐȸ Ãá°èÇмú´ëȸ(3ÀÏÂ÷) : 2024-05-04 0 69 2024-04-03
51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷